Gerresheimer Makes Solid Start to the Financial Year 2024
Organic growth: Revenues +2.8%, adjusted EBITDA +5.9%Capacity expansion in the Americas, Europe and Asia progresses according to planGuidance confirmedDUSSELDORF, GERMANY...
Pharmaceutical
Hamilton Thorne Ltd. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Beverly, Massachusetts--(Newsfile Corp. - April 10, 2024) - Hamilton Thorne Ltd. (TSX: HTL) (OTC Pink: HTLZF), Hamilton Thorne Ltd. a...
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
Conference Call and Webcast Scheduled for 1:30 p.m. PTALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical...
PharmaCord Announces Appointment of Cindy Padgett to Chief Commercial Officer
JEFFERSONVILLE, IN / ACCESSWIRE / April 10, 2024 / PharmaCord LLC, a leading provider of patient support services for the...
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
The study results revealed improvements in symptoms and quality of life in patients with musculoskeletal pain and inflammationTORONTO, April 10,...
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Findings underscore the liver safety of AD04 as compared to placebo in the prior Phase 3 clinical trialGLEN ALLEN, Va.,...
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
MISSISSAUGA, Ontario, April 10, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will...
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that...
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
FREMONT, CA, April 10, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing...
Eli Lilly’s and AstraZeneca’s Former Head of Research Dr. Jan Lundberg Invests in AlzeCure and is Proposed for Election to its Board
STOCKHOLM, SWEDEN / ACCESSWIRE / April 10, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB ("AlzeCure" or "the Company"), a...
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
Company not implementing a reverse split at this timeTop line results forthcoming for company's phase 3 OnTarget trial of crofelemer...
Xediton Pharmaceuticals Inc. To Present at The 2024 Bloom Burton & Co. Healthcare Investor Conference
Oakville, Ontario--(Newsfile Corp. - April 9, 2024) - Xediton Pharmaceuticals Inc., a leading Canadian specialty pharmaceutical company, will be participating...
Entos Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Edmonton, Alberta--(Newsfile Corp. - April 9, 2024) - Entos Pharmaceuticals, (Entos), a genetic medicines company pioneering the development of life-changing...
CancerIQ CEO Feyi Ayodele Named to Modern Healthcare’s 2024 Innovators List
CHICAGO--(BUSINESS WIRE)--#aheadofcancer--CancerIQ is proud to announce that co-founder and CEO Feyi Ayodele was recognized by Modern Healthcare as one of...
SRx Health Solutions Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 9, 2024) - SRx Health Solutions Inc., a leading Canadian healthcare service provider specializing in...
GE HealthCare to Announce First Quarter 2024 Results on April 30, 2024
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its first quarter 2024 financial results before...
Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States
BOULDER, CO / ACCESSWIRE / April 9, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing...
Curium Announces First Commercial Dose in the Netherlands of PYLCLARI® – an Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer
PARIS, April 09, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced that today in the Netherlands...
Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma
BASKING RIDGE, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage...
Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”
Panel of renowned cardiologists, all globally recognized experts in heart failure, will discuss the unmet medical need in pulmonary hypertension...